TSC Alert is a monthly e-newsletter for researchers and healthcare professionals. Subscribe to be the first to hear about our funding opportunities, research resources and conferences.

2022 Fall LAM Foundation Research Funding Cycle Now Open

Scientists who wish to apply for funding from The LAM Foundation must submit a Letter of Intent (LOI) using their online application system at ProposalCENTRAL by June 15. Pilot/Feasibility Award for $50,000 (One Year) Established Investigator Award for $150,000 (Two to Three Years) Francis X. McCormack Career Development Award for $180,000 (Three Years) To learn more about The LAM Foundation research awards and find the instructions on how to navigate our new platform click the button below. LAM GRANT OPPORTUNITIES Read More

Now Accepting Nominations for Preclinical Testing

Nominations accepted until Friday, June 10, 2022  Interested principal investigators (PI) are invited to nominate candidate therapeutics for testing in the TSC Preclinical Consortium’s tumor models. Please complete the short nomination form, available on the TSC Alliance Preclinical Consortium webpage. The form requests no more than two pages of text and/or figures to describe the rationale for the compound and its mechanism of action for TSC. The lead PI must also submit an NIH-style biosketch. Nominations will be accepted until Monday, August 1, 2022.   Companies interested in nominating compounds and retaining confidentiality and ownership of the data should not utilize the nomination... Read More

TSC Alliance® Partners with NeurologyLive™

The TSC Alliance has partnered with NeurologyLive to bring healthcare professionals treating neurological disorders the latest in research and practice. Check out our partner page. Subscribe to NeurologyLive to stay up to date on clinical trial news, FDA updates and more. Read More

Research Study on TSC and COVID-19

The TSC Alliance is collecting clinical information about individuals with TSC who were infected with COVID-19. Please circulate the following to your patients: The TSC Alliance is collecting clinical information in their TSC Natural History Database about individuals with TSC who were infected with COVID-19. TSC researchers will use this information to help determine how medications such as everolimus (Afinitor®, Zortress®) or sirolimus (Rapamune®) and other TSC conditions affect the risk of getting COVID-19 and its severity. If you or your loved one with TSC had COVID-19 confirmed by testing, please consider participating in the TSC Alliance Natural History Database.... Read More

Join Our Peer-to-Peer Listserv for Healthcare Professionals

The TSC Alliance invites healthcare professionals affiliated with a TSC Clinic, TSC Center of Excellence, or University Medical Center to subscribe to our private listserv: p2p@lists.tscalliance.org. Its primary purpose is for members to pose TSC-related cases or questions to their peers for feedback. Members may also use the listserv to seek opportunities for collaboration on TSC-related projects. The listserv is monitored to ensure it is being used for appropriate communications. Read More

TANDem Seed Grant Funding Available from UK Tuberous Sclerosis Association

  |  Grants

This year, together with the TAND consortium, The Tuberous Sclerosis Association in the UK is running their first ever TAND-centered funding round. The remit of this call is to offer small ‘seed’ grants (€2,000-€10,000 per award) to international researchers, in particular early career investigators (up to 10 years post PhD). Read More